UBS Group
NCSM icon

UBS Group’s NCS Multistage Holdings NCSM Stock Holding History

UBS Group’s Portfolio NCSM Stock Details NCSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67K Buy
1,084
+1,000
+1,190% +$47.2K ﹤0.01% 7211
2025
Q4 		$3.32K Sell
84
-23,619
-100% -$944K ﹤0.01% 9053
2025
Q3 		$1.21M Buy
23,703
+23,457
+9,535% +$882K ﹤0.01% 5401
2025
Q2 		$7.26K Buy
246
+192
+356% +$5.87K ﹤0.01% 9033
2025
Q1 		$1.89K Buy
54
+3
+6% +$89 ﹤0.01% 9430
2024
Q4 		$1.32K Buy
51
+50
+5,000% +$1.1K ﹤0.01% 9262
2024
Q3 		$20 Hold
1
– – ﹤0.01% 9313
2024
Q2 		$17 Sell
1
-69
-99% -$1.18K ﹤0.01% 9323
2024
Q1 		$1.11K Buy
70
+67
+2,233% +$1.05K ﹤0.01% 8225
2023
Q4 		$51 Buy
3
+2
+200% +$29 ﹤0.01% 8991
2023
Q3 		$16 Sell
1
-344
-100% -$6.07K ﹤0.01% 9159
2023
Q2 		$5.87K Buy
345
+339
+5,650% +$6.56K ﹤0.01% 7421
2023
Q1 		$143 Sell
6
-354
-98% -$8.56K ﹤0.01% 9182
2022
Q4 		$9K Buy
360
+25
+7% +$673 ﹤0.01% 8699
2022
Q3 		$7K Sell
335
-133
-28% -$3.82K ﹤0.01% 8889
2022
Q2 		$15K Buy
+468
New +$19.5K ﹤0.01% 7302
2021
Q3 		– Sell
-318
Closed -$10K – 9883
2021
Q2 		$10K Sell
318
-92
-22% -$2.5K ﹤0.01% 8054
2021
Q1 		$11K Buy
+410
New +$13.2K ﹤0.01% 7863
2020
Q2 		– Sell
-337
Closed -$4K – 8211
2020
Q1 		$4K Sell
337
-383
-53% -$10.7K ﹤0.01% 7405
2019
Q4 		$30K Sell
720
-820
-53% -$35.9K ﹤0.01% 6637
2019
Q3 		$62K Buy
1,540
+234
+18% +$11.9K ﹤0.01% 6065
2019
Q2 		$93K Buy
1,306
+306
+31% +$22.8K ﹤0.01% 5425
2019
Q1 		$104K Buy
1,000
+695
+228% +$77K ﹤0.01% 5041
2018
Q4 		$31K Buy
305
+186
+156% +$35.7K ﹤0.01% 6468
2018
Q3 		$39K Buy
119
+56
+89% +$17.7K ﹤0.01% 6351
2018
Q2 		$18K Buy
63
+10
+19% +$3.19K ﹤0.01% 6774
2018
Q1 		$16K Buy
53
+4
+8% +$1.31K ﹤0.01% 6568
2017
Q4 		$14K Sell
49
-15
-23% -$5.55K ﹤0.01% 6810
2017
Q3 		$31K Buy
64
+62
+3,100% +$27.2K ﹤0.01% 6135
2017
Q2 		$1K Buy
+2
New +$940 ﹤0.01% 7504

Other funds holding NCSM

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

UBS Group's NCSM Position: Q1 2026 in Review

UBS Group increased its NCS Multistage Holdings (NCSM) stake by 1,190% in Q1 2026, buying an estimated $47.2K and bringing the position to 1,084 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #7211.

UBS Group first reported a position in NCSM in Q2 2017 and has held it in 30 quarters since. The position peaked at $1.21M in Q3 2025. 40 funds tracked by Wall St. Rank hold NCSM as of Q1 2026.

  • UBS Group held 1,084 shares of NCS Multistage Holdings worth $67K as of Q1 2026.
  • UBS Group bought 1,000 NCS Multistage Holdings shares in Q1 2026, an estimated $47.2K.
  • NCS Multistage Holdings made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7211 holding.
  • UBS Group first reported a position in NCS Multistage Holdings in Q2 2017 and has held it in 30 quarters since.
  • UBS Group's NCS Multistage Holdings position peaked at $1.21M in Q3 2025.
  • 40 funds tracked by Wall St. Rank held NCS Multistage Holdings as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.